Charles River Laboratories International

NYSE
CRL
Stock
Yield per half year: +15.61%
Dividend yield: 0%
Sector: Healthcare

Charles River Laboratories International

240.00240.00210.00210.00180.00180.00150.00150.00120.00120.0090.0090.00Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
919.65 52.65 1646.85% 211.76 +334.28%
P/S 2.34 4.03 -42.02%
P/BV 2.7 10.87 -75.16%
P/FCF 15.95 39.64 -59.75%
Ev/Ebitda 20.65 16.1 28.21%
Ev/S 2.96 4.35 -31.92%
Ev/FCF 23.92 52.31 -54.27%
E/P 0.0013 0.2095 -99.39%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
14.35 19.07 -24.77% 19.28 -25.58%
ROE 0.2918 -83.32 -100.35%
ROA 0.131 6.38 -97.95%
ROIC 9.15 15.06 -39.25%
ROS 0.2542 9.34 -97.28%
ROCE 3.36 84.76 -96.04%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
1/10
4.69 1.01 365.18% 3.79 +23.54%
Nеt Debt/Ebitda 4.35 1.4 211.41%
Debt/Ratio 0.3618 0.2742 31.98%
Debt/Equity 0.7869 15.68 -94.98%
Debt/Net Income 264.54 6.8 3789.46%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.28 -100% 0 0%
Number of years of dividend growth 0 6.75 -100%
DSI 0 0.7413 -100%
Average dividend growth 0 -4.1 -100%
Average percentage for 5 years 0 1.33 -100%
Average percentage for payments 5.52 44.08 -87.47%
Difference from average difference in sector -1.28

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
38.51 12.47 208.82%
Growth impulse Ebitda in 5 years -24.33 -86.3 -71.81%
Growth impulse Net Income in 5 years -97.17 -75.86 28.09%
Growth impulse FCF in 5 years 32 -79.28 -140.36%
Growth impulse EPS in 5 years -97.23 4.34 -2340.32%
IP Score
2.95/10

Similar companies

Allergan

Bristol-Myers

Humana

Danaher Corporation

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription